Ayurveda Management of Systemic Lupus Erythromatus w.s.r. to Vatapradhan Vatarakta: A Case Report
Article Sidebar
Main Article Content
Abstract
Introduction:
Systemic Lupus Erythematosus (SLE) is a multisystem autoimmune disorder affecting connective tissues, where the immune system attacks healthy body tissues like skin, joints, kidneys, and other organs. Symptoms include fever, fatigue, myalgia, arthralgia, arthritis, malar rash, and oral ulcers. SLE can be correlated with Vatarakta in Ayurveda, presenting symptoms such as pain, swelling, and stiffness at multiple joints with blackish discoloration.
Objective: To explore the Ayurvedic management of Systemic Lupus Erythematosus (SLE) with reference to Vatapradhan Vatarakta.
Materials and Methods: As vitiated Vata is involved in the pathology of Vatarakta, Basti (an Ayurvedic enema therapy) is considered the most effective treatment for relieving this condition. Mridu Virechana (mild purgation) was selected before Basti to detoxify the body, considering the patient’s history of steroid use.
Results and Discussion: Both Vata and Rakta were vitiated, which contributed to the symptoms. The management plan focused on addressing both Vata and Rakta Dushti (imbalance). The detoxifying effects of Virechana were aimed at reducing the harmful impact of steroids, followed by Basti to balance Vata.
Conclusion: This case report highlights the potential of Ayurveda in managing autoimmune disorders like SLE by targeting the vitiation of Vata and Rakta through specific treatments like Basti and Virechana.
Keywords: Vatarakta, SLE, Basti, Virechana, Vatapradhan Vatarakta, Ayurveda
Downloads
Article Details
Section
This work is licensed under a Creative Commons Attribution 4.0 International License.
This article is published under the Creative Commons Attribution 4.0 International License (CC BY 4.0).
Authors retain copyright of their work and grant the International Journal of Ayurveda360 a non-exclusive license to publish, distribute, and reproduce the work in any medium, provided the original work is properly cited.
The CC BY 4.0 license permits unrestricted use, distribution, and reproduction in any medium, including commercial use, as long as appropriate credit is given to the original author(s) and source.
How to Cite
References
[1] Malaviya, A. N., Singh, R. R., Singh, Y. N., Kapoor, S. K., & Kumar, A. (1993). Prevalence of Systemic Lupus Erythematosus in India. Lupus, 2(2),115-118.
[2] Carakasamhita, Cikitsasthana, Vatashonitachikistam, 29/2. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025)
[3] Carakasamhita, Cikitsasthana, Vatashonitachikistam, 29/10-11. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025)
[4] Carakasamhita, Cikitsasthana, Vatashonitachikistam, 29/7. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025)
[5] Carakasamhita, Cikitsasthana, Vatashonitachikistam, 29/24. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025)
[6] Carakasamhita, Cikitsasthana, Vatashonitachikistam, 29/41. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025)
[7] Carakasamhita, Kalpasthana, Chaturangulakalpa, 08/12. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025)
[8] Carakasamhita,Sutrasthana, Vatashonitachikistam, 29/88. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025)
[9] Chakradatta of Sri Chakrapanidatta with Vaidayprabha Hindi commentry by Dr.Indradeva Tripathi, Chaukhambha Sanskrit Sansthan Varanasi ,Third Edition 1997 Amavatacikitsa verse -58,page 170.
[10] Carakasamhita, Sutrasthana, Deerghanjiviteeya, 1-3/30. Available from http://niimh.nic.in/ebooks/ecaraka/ (Accessed on 15/04/2025).